Steven Weinstein

Steven Weinstein has a diverse work experience in the healthcare industry. Steven is currently the CEO and Board Member of Gregor Diagnostics, where they oversee company operations. Steven also holds the role of Neuroscience Product Development Innovation Lead at Genentech.

Previously, Steven served as the Chairman of SpectraWAVE, Inc., a medical technology company. Steven was also a Board Member at Celero Systems, a precision medicine platform that focuses on detecting and reversing opioid overdose.

In addition, Steven worked as a Managing Member at Argus Innovation LLC and served as the Interim COO and Board Advisor at OpenBiome. Steven also held the position of Interim CEO and Board Member at ROX Medical.

Steven has extensive experience in venture capital and investment. Steven served as the Managing Director of Novartis Venture Fund, where they managed a global portfolio and led investments in biotech and medtech companies. Prior to that, they were a Principal at Prism Venture Partners, responsible for diligence and investment in medical device and biotech companies.

Early in their career, Steven worked at Mid-Atlantic Venture Funds as a Principal and Kauffman Fellow. Steven managed investments, served as a board observer, and focused on software companies.

Overall, Steven Weinstein has a strong background in healthcare leadership, venture capital, and investment, with a focus on biotech and medtech industries.

Steven Weinstein has a Bachelor of Science degree in Mechanical Engineering from Columbia University. Steven also holds a Master of Business Administration (MBA) from the University of Michigan - Stephen M. Ross School of Business.